Letters in Drug Design & Discovery

Papers
(The H4-Index of Letters in Drug Design & Discovery is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Preparation of Levothyroxine Transdermal Gels and Preliminary Pharmacokinetic Study in Hypothyroidism Rat Model171
Piperazine-based Semicarbazone Derivatives as Potent Urease Inhibitors: Design, Synthesis, and Bioactivity Screening85
Exploring Novel PLK1 Inhibitors based on Computational Studies of 2,4-Diarylaminopyrimidine Derivatives39
Molecular Docking, Molecular Dynamics Simulation, and Analysis of EGFR-derived Peptides against the EGF33
Repurposing Novel Antagonists for Targeting p7 Viroporin of HCV Using In Silico Approach33
Innovative approaches in insulin delivery: Exploring molecular techniques and system developments30
Ligand-based Pharmacophore Modeling, Molecular Docking and Simulation Studies for the Exploration of Natural Potent Antiangiogenic Inhibitors Targeting Heat Shock Protein 9030
A Review on Synthesis and Biological Potential of Dihydropyridines28
Recent Developments, Challenges and Opportunities in Targeting the KRAS Pathway27
Synthesis and Anticancer Activity of Oral Pt(IV) Prodrugs Containing α-furancarboxylate as an Axial Ligand27
Synthesis, Molecular Docking Studies, and In vitro Anticancer Evaluation of Novel Tolfenamic Acid Derivatives25
Plant Secondary Metabolites as Apoptosis-inducing Agents24
Synthesis, Characterization, and Evaluation of Sulfonium Lipids as Potential Nonviral Gene Vectors23
Computational Insights on Migraine and Anxiety in Association with BDNF19
Positive Expression of Paired Box 5 (Pax5) was Associated with Age, Tumor Location, and Tumor Size of Patients with Gastrointestinal Neuroendocrine Tumors (NETs)18
Screening and Structure-Activity Relationship of Potential Compounds against Proposed Targets of COVID-19 Infection18
Computational Study of Lactucine and its Derivatives to Investigate its Anti-cancerous Properties Targeting Apoptosis-inducing Protein17
0.27243995666504